Health Care -

Your samples

  • No items in the basket
  • Add more products View basket View products to order samples

Remove from basket

Are you sure you want to remove from the sample cart?

Your Language

English Português Español
Health Care
Health Care
  • Products and Applications
    • Product Finder
    • Dietary Supplements  
    • Eye, Ear & Nose  
    • Vaccine Adjuvants  
    • Omega 3 API  
    • Oral  
    • Parenteral  
    • Rectal and Vaginal  
    • Topical  
    • Veterinary Health  
      • Formulation Finder

        Formulation Finder

        Browse our range of fully developed formulations for inspiration and guidance.
        View
  • Technical Library
    • Formulation Finder
    • Brochures  
    • Datasheets and MSDS  
    • FDA IID Sheets  
    • Vaccine Adjuvants – Certificates of GMP Compliance  
    • Excipient Information Package  
    • Presentations  
    • Product Overview Sheets  
    • Videos  
    • Webinars  
      • Product Finder

        Product Finder

        Find a product to suit your needs from our high purity excipients portfolio.
        Product Finder
  • Discovery Zone
    • Product Effects
      • SEDDS and SMEDDS  
      • Increased Vaccine Efficacy  
      • Solubilisers and Emulsifiers  
      • Solvents  
      • Penetration Enhancers  
      • Controlled Release  
      • Skin Barrier Repair with Lanolin  
      • Film Forming Polymers  
    • Chemical Industry Helping to Fight COVID-19  
    • Our Technologies
      • Super Refined Excipients  
      • API grade Omega 3  
      • Vaccine Adjuvant Technology  
      • New Drug Delivery Technology – ProSilic®  
    • Emulsifier Selector  
    • Pharmaceutical Solubility Guide  
    • Veterinary Solubility Guide  
    • Leaders in Regulatory Excellence  
    • How We Can Help  
    • Events Calendar
      • Smarter Innovation Through Quality  
      • Product Effects

        Product Effects

        View our product offerings.
        View
  • News
    • Business News  
    • Events  
    • Innovation  
    • Sustainability  
    • Trends  
      • Events Calendar

        Events Calendar

        We will be present at key industry events taking place over the year around the globe.
        Events
  • Contact  
  1. Home
  2. News
  3. 2018
  4. 08
  5. Croda Invests in SiSaf's Novel Bio-Courier Technology

News categories

  • Business News
  • Events
  • Innovation
  • Sustainability
  • Trends

Investment in SiSaf's Novel Bio-Courier Technology

Business News, Innovation
1 Aug 2018

Croda International Plc (‘Croda’) and SiSaf Ltd (‘SiSaf’) have today announced an exciting new strategic partnership. Croda, the name behind high performance ingredients and technologies that are relied on by industries and consumers everywhere, has agreed a commercial arrangement with SiSaf, a pioneering UK based bio-pharmaceutical company. The arrangement involves the use and development of SiSaf’s patented bio-courier, ProSilic®, a novel drug delivery technology. Croda has also acquired a minority shareholding in SiSaf.

 

ProSilic will give Croda’s customers access to the next generation of targeted and controlled drug delivery, which can be tailored to meet their specific needs, whilst offering exceptional safety and versatility. This sustainable technology uses biodegradable silicon particles to improve stability, solubility and ultimately the performance of a wide range of active ingredients across many delivery systems.

 

Croda’s investment is a major contributor to SiSaf’s latest round of capital funding that will enable them to accelerate a commercial route to market for this unique technology. SiSaf will also benefit from Croda’s very successful global trading model, further supported by its leading R&D and regulatory expertise. While the partnership will primarily focus on Croda’s Health Care market, the diversity of ProSilic technology will see research projects take place in much wider applications.

 

Dr Nick Challoner, President Life Sciences, Croda, said; “The cultural fit between Croda and SiSaf, with a strong focus on innovation and sustainability, means that this strategic partnership will bring great benefits to our customers and their formulations. We are hugely excited that through this investment we will be able to exclusively bring this novel, patented technology to our Health Care customers worldwide, enabling them to enhance the performance of their products.”

 

Dr Suzanne Saffie-Siebert, Founder and CEO of SiSaf, said; “This is more than an investment of capital. It is an investment in our belief that good science equals good business. Our strategic partnership with Croda will turn potential into reality much faster than SiSaf could have achieved alone. We are extremely proud to be working with such an impressive organisation to boost the development of ProSilic technology and together I am sure we will exceed the expectations of Croda’s customers worldwide.”

For more information, please use our online contact form.

Share this page

  • Click to print this page
  • LinkedIn
  • Facebook
  • Click to share this page on twitter
  • Click to email
    Email Address
    Are you human?
Product Finder Search our product database
MSDS Search for a material safety datasheet
Contact Us Contact your local office

Health Care

We at Croda contribute to a healthier world by offering ingredients and formulation expertise which help our pharmaceutical customers get the best performance from their active ingredients.

Follow us on social media
  • Health Care on LinkedIn

Corporate

  • Products and markets
  • Where we operate
  • Current vacancies
  • Annual Report
  • Sustainability Reports
  • GRI Report
Visit our corporate site
© 2021 Croda International Plc
© 2021 Croda International Plc | Terms and Conditions | Privacy Policy | Accessibility statement

About cookies on this site
By continuing to use this website, you agree to the use of cookies. You can find out more details in our Privacy policy.